Riverview Capital Advisers, LLC Moderna, Inc. Transaction History

Riverview Capital Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $71,054 - $93,311	-737 Reduced 12.48%	5,170 $534,000
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $490,945 - $665,075	-4,143 Reduced 41.22%	5,907 $717,000
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $6,783 - $9,851	50 Added 0.5%	10,050 $1.54 Million
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $5,919 - $10,502	-50 Reduced 0.5%	10,000 $1.8 Million
Q3 2022 Feb 07, 2023	BUY	$118.07 - $194.18 $5,903 - $9,709	50 Added 0.5%	10,050 $1.19 Billion
Q1 2022 Feb 07, 2023	SELL	$126.46 - $235.05 $6,323 - $11,752	-50 Reduced 0.5%	10,000 $1.72 Billion
Q4 2021 Feb 07, 2023	BUY	$225.82 - $368.51 $2.27 Million - $3.7 Million	10,050 New	10,050 $2.55 Billion

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Riverview Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Riverview Capital Advisers, LLC with notifications on news.